Biostar Pharmaceuticals, Inc. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/501626c4-b7e3-4443-92c1-5fbb02122658/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2016 | $-3.6M | 2016-01-01 – 2016-12-31 | evidence 0001185185-17-000916 |
| FY 2015 | $-23.8M | 2015-01-01 – 2015-12-31 | evidence 0001185185-16-004237 |
| FY 2014 | $-1.3M | 2014-01-01 – 2014-12-31 | evidence 0001185185-15-000919 |
| FY 2013 | $508.2k | 2013-01-01 – 2013-12-31 | evidence 0001185185-14-000771 |
| FY 2012 | $-21.8M | 2012-01-01 – 2012-12-31 | evidence 0001185185-13-000819 |
| FY 2011 | $18.2M | 2011-01-01 – 2011-12-31 | evidence 0001185185-12-000487 |
| FY 2010 | $23.6M | 2010-01-01 – 2010-12-31 | evidence 0001185185-12-000487 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Biostar Pharmaceuticals, Inc. — all facts · Revenue · Net Income